Dr. Ann Marie Schmidt is an internationally recognized expert in vascular biology, a field that applies basic research in a range of disciplines to gain insights into disease pathogenesis and to develop new therapeutic approaches for the treatment of arteriosclerosis, diabetes, inflammation, thrombosis, and malignancy. Dr. Schmidt received her M.D. (honors) from New York University School of Medicine.

After training in clinical medicine and hematology / oncology, Dr. Schmidt embarked on her career as a full-time investigator. She is an Associate Professor of Surgical Science and Medicine at the College of Physicians and Surgeons of Columbia University. Dr. Schmidt has presented her work on RAGE at many national and international scientific meetings, including the Gordon Research Conference of Vascular Biology, the American Heart Association meeting on Vascular Biology, and the Keystone Symposia.

Dr. Schmidt is known for innovative studies in the fields of diabetic complications (targeting RAGE), Alzheimer's disease, and, more recently, inflammation and tumor biology relevant to RAGE. Dr. Schmidt's research has utilized the tools of basic science to address issues relevant to important clinical problems in vascular diseases, particularly diabetes. Dr. Schmidt has been the recipient of an award in research at Columbia University, a fellowship from the Juvenile Diabetes Research Foundation, and a Clinician-Scientist award from the National Institutes of Aging. She is, at present, an Established Investigator of the American Heart Association. She is currently Co-principal Investigator on two Program Project Grants, in addition to several other peer-reviewed grants. Her publications include over 38 peer-reviewed papers and over 12 review/book chapters.